glimepiride

insulin ; Homo sapiens







84 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 12547850 Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. 2003 Feb 4
52 12637120 Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. 2003 Jan 2
53 12795658 Glimepiride reduces mononuclear activation of the redox-sensitive transcription factor nuclear factor-kappa B. 2003 Jul 1
54 12822388 [Glimepiride--an oral antidiabetic agent]. 2003 1
55 14565810 Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus. 2003 Nov 2
56 14974179 [Glimepiride in daily practice]. 2003 1
57 12196435 Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes. 2002 Sep 2
58 12401758 Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes. 2002 Nov 1
59 12453949 Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide. 2002 Dec 9
60 12568204 Immunoreactive insulin response to a single dose of glimepiride in lean type 2 diabetic subjects. 2002 Oct 3
61 11160869 The sulfonylurea glimepiride regulates intracellular routing of the insulin-receptor complexes through their interaction with specific protein kinase C isoforms. 2001 Feb 11
62 11336617 Clinical review of glimepiride. 2001 Apr 2
63 11455676 Comparison of the effects of three sulfonylureas on in vivo insulin action. 2001 2
64 11460577 Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers. 2001 1
65 11496829 [Glimepiride (Amaryl): a review of its pharmacological and clinical profile]. 2001 Jul 1
66 10872292 [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs]. 2000 May 25 1
67 11277315 Insulin release form isolated, human islets after acute or prolonged exposure to glimepiride. 2000 1
68 10199156 [Sulfonylurea drug--a new sulfonylurea drug for type 2 diabetes]. 1999 Mar 1
69 10543411 Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man. 1999 2
70 10605995 Oral pharmacologic management of type 2 diabetes. 1999 Dec 1
71 9561345 Glimepiride. A review of its use in the management of type 2 diabetes mellitus. 1998 Apr 3
72 9652156 The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe. 1998 May 2
73 9653594 Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Glimepiride Combination Group. 1998 Jul 2
74 9702849 A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful. 1998 Jul 2
75 15010702 Preclinical studies of glimepiride. 1998 May 7
76 15010703 Clinical trials with glimepiride. 1998 May 2
77 9184703 Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus. 1997 Jun 1
78 9223393 Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. 1997 Jul 2
79 8911976 Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide. 1996 Sep 2
80 8911981 The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. 1996 Sep 3
81 8911982 The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide. 1996 Sep 2
82 8529506 Clinical profile of glimepiride. 1995 Aug 2
83 8216442 Dose relationship of stimulated insulin production following intravenous application of glimepiride in healthy man. 1993 Aug 1
84 8243832 The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. 1993 Dec 5